ISSN 2149-3235 | E-ISSN 2149-3057
SEXUAL MEDICINE AND MALE INFERTILITY - Original Article
Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center
1 Department of Urology, King George's Medical University, Lucknow, India  
Turk J Urol ; : -
DOI: 10.5152/tud.2019.75044
Key Words: CML; ischemia; low flow; malignancy; priapism; shunts
Abstract

Objective: Data on outcome of patients with ischemic priapism (IP) due to malignant causes are scant. In this study, we compared outcome of patients with malignant vs. non-malignant IP in adult North Indian men.

 

Material and methods: We analyzed medical records of patients with IP who presented to a large tertiary care referral center from August 2005 to July 2017.

 

Results: Data of 71 patients were analyzed. The median age was 30 years (range 17-65). The average duration of symptoms was 4.39 days (range 1-10). Most common etiology was idiopathic in 29 (40.84%), chronic myeloid leukemia (CML) in 24 (33.80%), and drug-induced in 15 patients. Thirty-eight patients underwent distal shunts, while nine patients underwent proximal shunt procedure. Men with malignant priapism (CML) had significantly lower success rates with interventions, prolonged hospital stay, and higher complications (p<0.05). Most complications after shunt surgery were minor (Clavein grade 1 and 2). After shunt surgery, bleeding at shunt site was observed in 14 cases, and wound infection developed in five patients. Prevalence of erectile dysfunction in patients at follow-up was high.

 

Conclusion: Men with malignant priapism (CML) had significantly lower success rates with interventions, prolonged hospital stay, and higher complications than men with non-malignant priapism.

 

Cite this article as: Kumar M, Garg G, Sharma A, Pandey S, Singh M, Sankhwar SN. Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center. Turk J Urol 2019; DOI: 10.5152/tud.2019.75044

Key Words
Authors
All
Survey
AVES | Copyright © 2018 Turkish Association of Urology | Latest Update: 04.02.2019